[1]
2026. In Silico Targeting and Structural Stabilization of LRRC66 by 3′,5,7-Trihydroxy-4′- methoxy flavanone A Computational Strategy for Therapeutic Modulation of Cardiac Remodeling. Pharmabiologia. 2, 1 (Aug. 2026), 21–35.